Aditxt’s (Nasdaq: ADTX) Adimune(TM) Program Has Initiated the Manufacturing Process of Immunotherapeutic Drug Candidate, ADI(TM)-100 in Preparation for Planned Psoriasis First-in-Human Trials

October 21, 2022

Biotechnology

MAIA Biotechnology Announces $1.00 Million Private Placement

April 23, 2024
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

April 23, 2024
Nutriband Inc. Announces $8.4M Private Placement

April 19, 2024
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

April 18, 2024